Latest TroVax Stories
COPENHAGEN, Denmark, April 28, 2015 /PRNewswire/ -- DanDrit Biotech USA, Inc.
ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Highly Refractory Patients LAWRENCEVILLE, N.J., April 15, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ:
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
BOTHELL, Wash. and VANCOUVER, B.C., Sept.16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
AUSTIN, Texas, Sept.
ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.